Skip to main content

Research Repository

Advanced Search

Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England

Hirst, Jennifer; Mi, Emma; Copland, Emma; Patone, Martina; Coupland, Carol; Hippisley-Cox, Julia

Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England Thumbnail


Authors

Jennifer Hirst

Emma Mi

Emma Copland

Martina Patone

CAROL COUPLAND carol.coupland@nottingham.ac.uk
Professor of Medical Statistics

Julia Hippisley-Cox



Abstract

Background: People with blood cancers have increased risk of severe outcomes from COVID-19 and were prioritised for vaccination. Methods: Individuals in the QResearch database aged 12 years and above on 1st December 2020 were included in the analysis. Kaplan–Meier analysis described time to COVID-19 vaccine uptake in people with blood cancer and other high-risk disorders. Cox regression was used to identify factors associated with vaccine uptake in people with blood cancer. Results: The analysis included 12,274,948 individuals, of whom 97,707 had a blood cancer diagnosis. 92% of people with blood cancer received at least one dose of vaccine, compared to 80% of the general population, but there was lower uptake of each subsequent vaccine dose (31% for fourth dose). Vaccine uptake decreased with social deprivation (HR 0.72, 95% CI 0.70, 0.74 for most deprived versus most affluent quintile for first vaccine). Compared with White groups, uptake of all vaccine doses was significantly lower in people of Pakistani and Black ethnicity, and more people in these groups remain unvaccinated. Conclusions: COVID-19 vaccine uptake declines following second dose and there are ethnic and social disparities in uptake in blood cancer populations. Enhanced communication of benefits of vaccination to these groups is needed.

Citation

Hirst, J., Mi, E., Copland, E., Patone, M., Coupland, C., & Hippisley-Cox, J. (2023). Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England. European Journal of Cancer, 183, 162-170. https://doi.org/10.1016/j.ejca.2023.02.001

Journal Article Type Article
Acceptance Date Feb 2, 2023
Online Publication Date Feb 9, 2023
Publication Date Apr 1, 2023
Deposit Date Feb 22, 2023
Publicly Available Date Mar 3, 2023
Journal European Journal of Cancer
Print ISSN 0959-8049
Electronic ISSN 1879-0852
Publisher Elsevier BV
Peer Reviewed Peer Reviewed
Volume 183
Pages 162-170
DOI https://doi.org/10.1016/j.ejca.2023.02.001
Keywords COVID-19 vaccine; Blood cancer; Vaccination uptake; Health inequalities
Public URL https://nottingham-repository.worktribe.com/output/17386161
Publisher URL https://www.sciencedirect.com/science/article/pii/S095980492300059X
Additional Information This article is maintained by: Elsevier; Article Title: Uptake of COVID-19 vaccination in people with blood cancer: population-level cohort study of 12 million patients in England; Journal Title: European Journal of Cancer; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejca.2023.02.001; Content Type: article; Copyright: © 2023 The Author(s). Published by Elsevier Ltd.

Files




You might also like



Downloadable Citations